Vitamin B3 as a possible treatment for glaucoma

Scientists find new way of predicting COVID-19 vaccine efficacy
17 May 2021
Lack of sleep is harming health care workers–and their patients
17 May 2021

Vitamin B3 as a possible treatment for glaucoma

Glaucoma involves a high risk of losing sight. Researchers at Karolinska Institutet and St. Erik Eye Hospital, among others, have now studied the effects of nicotinamide, the amide of vitamin B₃, on animal and cell models for glaucoma. The study, published in Redox Biology, may be a future neuroprotective therapy in glaucoma in humans. A clinical trial will start in the autumn.

Comments are closed.